Log in

goodpods headphones icon

To access all our features

Open the Goodpods app
Close icon
The Retina Channel Podcast - E87- Pachychoroid Disease Spectrum- A deep Dive- Dr. Angie Fong

E87- Pachychoroid Disease Spectrum- A deep Dive- Dr. Angie Fong

05/16/25 • 75 min

The Retina Channel Podcast

This episode is a reproduction of the second retina-focused EyeNovation webinar series and a result of a special collaboration between Canadian Retina Society and Canadian Ophthalmological Society.

Dr. Angie Fong from the University of Hong Kong gives a fantastic overview of pachychoroid spectrum of conditions with a focus on central serous chorioretinopathy and polypoidal choroidal vasculopathy. She gives an in-depth review of pathogenesis, recent clinical trials, and emerging management strategies and discussed the incidence and risk factors for PDS progression based on natural observation studies.

Dr. Wai-Ching Lam from the University of British Columbia is the moderator for this webinar.

plus icon
bookmark

This episode is a reproduction of the second retina-focused EyeNovation webinar series and a result of a special collaboration between Canadian Retina Society and Canadian Ophthalmological Society.

Dr. Angie Fong from the University of Hong Kong gives a fantastic overview of pachychoroid spectrum of conditions with a focus on central serous chorioretinopathy and polypoidal choroidal vasculopathy. She gives an in-depth review of pathogenesis, recent clinical trials, and emerging management strategies and discussed the incidence and risk factors for PDS progression based on natural observation studies.

Dr. Wai-Ching Lam from the University of British Columbia is the moderator for this webinar.

Previous Episode

undefined - E86-8-Year Cognitive Outcomes of Intravitreal Bevacizumab for ROP- Dr. Wei-Chi Wu

E86-8-Year Cognitive Outcomes of Intravitreal Bevacizumab for ROP- Dr. Wei-Chi Wu

Dr. Wu discusses prospective cognitive outcomes of children who had treatment for Retinopathy of Prematurity. The analysis suggests that cognitive outcomes were similar for children who had either laser or anti-VEGF injections for ROP treatment.

Dr. Wu will be one of the invited guest speakers at the Canadian Retina Society meeting in Vancouver, BC from April 25-April 27, 2025. You can register for this meeting at:

https://crsscr.ca/meeting

Discussed article:

Wu PL, Shih CP, Huang YS, Chen HC, Hsueh YJ, Lee CW, Chiang MC, Lien R, Lee CC, Chu SM, Chou HD, Liu L, Chen KJ, Hwang YS, Lai CC, Wu WC. ADMINISTERING INTRAVITREAL BEVACIZUMAB FOR RETINOPATHY OF PREMATURITY: 8-Year Cognitive Outcomes In A Prospective Cohort. Retina. 2024 Nov 1;44(11):1952-1960. doi: 10.1097/IAE.0000000000004222. PMID: 39121508.

Episode Comments

Generate a badge

Get a badge for your website that links back to this episode

Select type & size
Open dropdown icon
share badge image

<a href="https://goodpods.com/podcasts/the-retina-channel-podcast-386218/e87-pachychoroid-disease-spectrum-a-deep-dive-dr-angie-fong-91348841"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to e87- pachychoroid disease spectrum- a deep dive- dr. angie fong on goodpods" style="width: 225px" /> </a>

Copy